US › Healthcare

HCW Biologics Inc (HCWB)

US · Healthcare · Biotechnology

$3.60+7.78%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$6.5M
Revenue YoY
+129080.7%
Net profit
$4.1M
Profit YoY
+288.1%
EPS
$2.22
EPS estimate
$-2.64
Net margin
63.2%

EPS came in at 2.22 against a street estimate of -2.64 — a beat of 184.1%.

Key statistics

Market cap
$5.1M
Forward P/E
0.0
P/B
0.90
Book value
$5.13
EPS (TTM)
$-49.74
52-week high
$44.10
52-week low
$1.50
50-day MA
$6.88
200-day MA
$8.07
Beta
2.30

Analyst view

Analysts rate HCW Biologics Inc a buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $30.00.

Shareholding

Insiders
9.24%
Institutions
8.59%

Largest institutional holders

FundStake
HRT FINANCIAL LLC2.78%
Virtu Financial LLC0.50%
Geode Capital Management, LLC0.37%
Citadel Advisors Llc0.27%
Tower Research Capital LLC0.15%
Jane Street Group LLC0.15%
Vanguard Capital Management, LLC0.13%
Citigroup Inc0.11%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for HCW Biologics Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.